3 Things You Really Need to Know About Marijuana Stock MedReleaf

When Canadian medical marijuana producer MedReleaf (NASDAQOTH: MEDFF) (TSX: LEAF) conducted its initial public offering in June, it became the biggest marijuana stock IPO ever in North America. The offering netted a cool $75 million, outraising other Canadian marijuana companies, including Aphria (NASDAQOTH: APHQF), Aurora Cannabis (NASDAQOTH: ACBFF), and Canopy Growth (NASDAQOTH: TWMJF).

That's the good news. The bad news is that MedReleaf stock has underperformed all of its peers since the IPO. Does this mean that the stock has a flaw that the others don't? Or is its laggard status only temporary? Here are three things that you need to know before buying MedReleaf stock.

Image source: Getty Images.

Source: Fool.com